Brief: Imunon Enters Into Technology Evaluation Agreement With Acuitas Therapeutics
10/11/2022 14:38
Nov 10 (Reuters) - Imunon Inc IMNN.O :
* IMUNON ENTERS INTO TECHNOLOGY EVALUATION AGREEMENT WITH
ACUITAS
THERAPEUTICS TO EVALUATE IMUNON'S PLACCINE PLASMID DNA WITH
ACUITAS' LIPID NANOPARTICLE DELIVERY SYSTEM
Source text for Eikon: ID:nGNX7bXkRZ
Further company coverage: IMNN.O
((reuters.briefs@thomsonreuters.com;))